On 8 Oct 2026, RIDGE OUTDOOR (02720.HK) said its unit agreed to buy the operating assets of UK fishing rod brand Harrison Advanced Rods.
On 8 Oct 2026, PLUS GP HOLDING (02486.HK) agreed to buy the remaining 40% of two subsidiaries from a connected person for RMB21.64m and RMB19.24m.
On 8 Oct 2026, WOER (09981.HK) said subsidiary Leting Zhilian completed a RMB300m capital increase, lifting its stake to 94.39%.
On 8 Oct 2026, NEW SILKROAD (00472.HK) said unit KSR will pay about KRW5bn (~HK$27m) for stakes and new shares in two targets, a discloseable transaction.
On 8 Oct 2026, NUOBIKAN (02635.HK) issued a placement supplement, earmarking proceeds for industrial AI O&M R&D and strategic buys; ~HKD 39.3mn available.
On 8 Oct 2026, HUARONG ENERGY (01101.HK) said Leung Yin Fai will resign as company secretary and authorised representative from 30 Oct, breaching Rule 3.28.
On 8 Oct 2026, LONGCHEER (09611.HK) filed three A-share notices: buybacks of 6.64mn shares for RMB 250mn YTD, a fund stake buy and a capital change.
On 8 October 2026, SBP GROUP (01177.HK) said the Phase III PACER-III trial of its TQC3721 inhalation suspension for COPD in China completed full enrolment.
On October 8, 2026, the Hong Kong ETF market was shaped by a defensive tilt. Dividend and high-yield plays led the advance, with the Bosera China Reform Hong Kong Central-SOEs High Dividend Yield Index ETF (Listed Class) topping the gainers at +1.40%; six of the top ten gainers were dividend or high-dividend related products. On the downside, AI, technology and semiconductor themes retreated sharply, led by the Hang Seng AI Advancement ETF at −5.76%, with every name in the top ten decliners falling at least 4.3%. Among southbound (Stock Connect) ETFs, dividend products edged higher while Hong Kong-Korea tech and biotech themes led the declines.
The 110.4150 million H shares held in aggregate by 18 cornerstone investors of METIS TECHBIO-P (07666.HK) will see their lock-up period end on November 12, 2026, with formal release starting from November 13; the corresponding market value based on the offer price is approximately HKD 1.159 billion.
On 8 October 2026, RIBOLIFE (06938.HK) filed a Phase I clinical trial application in the EU for RBD3133, an INHBE-targeting siRNA for obesity.
On 7 Oct 2026, HERBS GROUP (02593.HK) said its company secretary and authorised representative changed, with the Group's co-CFO appointed the same day.
On 6 Oct 2026, AOM INT'L (00381.HK) unveiled its Twelve Dynasties Wine project, blending rice wine with cultural export and a 100m-token TDT on BSC.
On 5 October 2026, SINOPHARM TECH (08156.HK) said its public float returned to about 25.01% after an independent director sold 380,000 shares on-exchange.
On 5 October 2026, QINGLING MOTORS (01122.HK) signed a repurchase deal with Haitong Unitrust (01905.HK) for 30 new energy vehicles, capped at RMB 12,636,030.
On 5 October 2026, CN HEALTH TECH (01069.HK) said its annual results for the year ended 30 June 2026 are delayed, with shares suspended since 2 October 2026.
